Citadel Advisors
TDAC

Citadel Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Citadel Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,479
Closed -$176K – 15701
2025
Q1 		$176K Buy
+17,479
New +$176K ﹤0.01% 10629

Other funds holding TDAC

WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Citadel Advisors's TDAC Position: Q2 2025 in Review

Citadel Advisors sold out of Translational Development Acquisition Corp (TDAC) in Q2 2025, closing a stake of 17,479 shares — an estimated $176K sold.

Citadel Advisors first reported a position in TDAC in Q1 2025 and held it in 1 quarter. The position peaked at $176K in Q1 2025. 38 funds tracked by Wall St. Rank hold TDAC as of Q2 2025.

  • Citadel Advisors reported no remaining Translational Development Acquisition Corp position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 17,479 Translational Development Acquisition Corp shares in Q2 2025, an estimated $176K.
  • Citadel Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 1 quarter.
  • Citadel Advisors's Translational Development Acquisition Corp position peaked at $176K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.